Original Air Date 8.25.22
This
course has expired and is no-longer eligible for CLE.
An in-depth look at the impact of last year’s Supreme Court decision on assignor estoppel, Minerva Surgical, Inc. v. Hologic, Inc. (2021). That case opened a veritable Pandora’s box of new possibilities when drafting assignments and other contracts affecting ownership of patent rights, complicating how such agreements are negotiated and how attorneys advise clients about such matters. Join us to explore how best to navigate the traps for the unwary that can arise post-Minerva. We will review Minerva’s key holdings, its impact for future cases, and practical considerations for patent assignments going forward.
Presented by:
Austen Zuege, Westman, Champlin & Koehler, P.A.
Jeanette Roorda, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
AIPLA is an approved provider by most jurisdictions requiring CLE. Each program requires individual jurisdiction approval, and each jurisdiction has different approval guidelines and time frames so programs may not be pre-approved for CLE. Program accreditation is sought in all attendee requested jurisdictions and may be available for up to one year after the original air date. Specialized credits (Ethics, Elimination of Bias, Diversity, Equity & Inclusion, Technology, etc.) approval varies by jurisdiction. CLE reporting and/or certificates of attendance may take up to 4 weeks for processing.
For information on CLE accreditation and processing, please contact the AIPLA CLE Department at cle@aipla.org.